Success of a Transdisciplinary Peri-Operative Pathway for Patients Undergoing Emergency Laparotomy During the COVID-19 Pandemic: A CUSUM Analysis.

IF 1.5 4区 医学 Q3 SURGERY
Kai Siang Chan, Woan Wui Lim, Jingwen Lee, Yu Jing Ong, Marc Weijie Ong, Sivaraj Gunasekaran, Jerry Tiong Thye Goo
{"title":"Success of a Transdisciplinary Peri-Operative Pathway for Patients Undergoing Emergency Laparotomy During the COVID-19 Pandemic: A CUSUM Analysis.","authors":"Kai Siang Chan, Woan Wui Lim, Jingwen Lee, Yu Jing Ong, Marc Weijie Ong, Sivaraj Gunasekaran, Jerry Tiong Thye Goo","doi":"10.1111/ans.70234","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Emergency laparotomy (EL) is associated with high post-operative morbidity. This study aims to evaluate the sustainability of our peri-operative pathway for EL (Emergency Laparotomy Pathway (ELAP)) during the COVID-19 pandemic.</p><p><strong>Methods: </strong>This is a single-center retrospective study on patients who underwent EL following ELAP implementation from Jan 2019-Dec 2022. Exclusion criteria were EL for trauma or vascular surgery. The cohort was divided based on the COVID-19 pandemic (COVID was defined from 7 Feb 2020-25 Apr 2022). Cumulative sum (CUSUM) analysis was used to assess the chronologic performance of ELAP. Our primary outcomes were efficiency outcomes (time to surgery, presence of senior surgeon/anaesthetist in theatre and post-operative geriatric review). Our secondary outcomes were post-operative complications, major morbidity, and 30-day mortality.</p><p><strong>Results: </strong>There were 564 patients (30.5% pre-COVID, 52.1% COVID, 17.4% post-COVID). The median age was 66.0 years, and 57.6% had ASA score ≥ 3. The commonest indication for EL was intestinal obstruction (56.9%). Overall major morbidity was 14.0%, and 30-day mortality was 2.8%. CUSUM analysis showed two phases-exploration phase (Case 1-158) and proficiency phase (Case 159-564); an inflection point was noted following the exploration phase, which showed a more sustained performance in achieving post-operative geriatric review and absence of post-operative complications or major morbidity. There was no observed relationship between COVID-19 and the performance of ELAP in both efficiency and clinical outcomes.</p><p><strong>Conclusion: </strong>The good performance of ELAP was sustained at 4 years following its initial implementation despite the COVID-19 pandemic, which resulted in major disruptions to healthcare delivery.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ANZ Journal of Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ans.70234","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Emergency laparotomy (EL) is associated with high post-operative morbidity. This study aims to evaluate the sustainability of our peri-operative pathway for EL (Emergency Laparotomy Pathway (ELAP)) during the COVID-19 pandemic.

Methods: This is a single-center retrospective study on patients who underwent EL following ELAP implementation from Jan 2019-Dec 2022. Exclusion criteria were EL for trauma or vascular surgery. The cohort was divided based on the COVID-19 pandemic (COVID was defined from 7 Feb 2020-25 Apr 2022). Cumulative sum (CUSUM) analysis was used to assess the chronologic performance of ELAP. Our primary outcomes were efficiency outcomes (time to surgery, presence of senior surgeon/anaesthetist in theatre and post-operative geriatric review). Our secondary outcomes were post-operative complications, major morbidity, and 30-day mortality.

Results: There were 564 patients (30.5% pre-COVID, 52.1% COVID, 17.4% post-COVID). The median age was 66.0 years, and 57.6% had ASA score ≥ 3. The commonest indication for EL was intestinal obstruction (56.9%). Overall major morbidity was 14.0%, and 30-day mortality was 2.8%. CUSUM analysis showed two phases-exploration phase (Case 1-158) and proficiency phase (Case 159-564); an inflection point was noted following the exploration phase, which showed a more sustained performance in achieving post-operative geriatric review and absence of post-operative complications or major morbidity. There was no observed relationship between COVID-19 and the performance of ELAP in both efficiency and clinical outcomes.

Conclusion: The good performance of ELAP was sustained at 4 years following its initial implementation despite the COVID-19 pandemic, which resulted in major disruptions to healthcare delivery.

COVID-19大流行期间急诊剖腹手术患者的跨学科围手术期途径的成功:CUSUM分析
背景:急诊剖腹手术(EL)与术后高发病率相关。本研究旨在评估在COVID-19大流行期间我们的EL(紧急剖腹手术路径(ELAP))围手术期路径的可持续性。方法:这是一项单中心回顾性研究,研究对象是2019年1月至2022年12月实施ELAP后接受EL治疗的患者。排除标准为EL外伤或血管手术。该队列根据COVID-19大流行进行划分(COVID的定义为2020年2月7日至2022年4月25日)。累积和(CUSUM)分析用于评估ELAP的时间表现。我们的主要结果是效率结果(手术时间、高级外科医生/麻醉师在手术室的出现和手术后的老年复查)。我们的次要结局是术后并发症、主要发病率和30天死亡率。结果:564例患者(术前30.5%,术后52.1%,术后17.4%)。中位年龄为66.0岁,57.6%的患者ASA评分≥3分。EL最常见的适应症是肠梗阻(56.9%)。总体主要发病率为14.0%,30天死亡率为2.8%。CUSUM分析显示两个阶段:探索阶段(病例1-158)和熟练阶段(病例159-564);在探索阶段之后出现了一个拐点,在实现术后老年复查和没有术后并发症或主要发病率方面表现出更持久的表现。在效率和临床结果方面,没有观察到COVID-19与ELAP的表现之间的关系。结论:尽管2019冠状病毒病(COVID-19)大流行对医疗服务造成了重大干扰,但ELAP在最初实施4年后仍保持了良好的表现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ANZ Journal of Surgery
ANZ Journal of Surgery 医学-外科
CiteScore
2.50
自引率
11.80%
发文量
720
审稿时长
2 months
期刊介绍: ANZ Journal of Surgery is published by Wiley on behalf of the Royal Australasian College of Surgeons to provide a medium for the publication of peer-reviewed original contributions related to clinical practice and/or research in all fields of surgery and related disciplines. It also provides a programme of continuing education for surgeons. All articles are peer-reviewed by at least two researchers expert in the field of the submitted paper.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信